首页> 美国卫生研究院文献>Biophysical Journal >Role of Cytoskeleton in Controlling the Disorder Strength of Cellular Nanoscale Architecture
【2h】

Role of Cytoskeleton in Controlling the Disorder Strength of Cellular Nanoscale Architecture

机译:细胞骨架在控制细胞纳米尺度结构无序强度中的作用。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Cytoskeleton is ubiquitous throughout the cell and is involved in important cellular processes such as cellular transport, signal transduction, gene transcription, cell-division, etc. Partial wave spectroscopic microscopy is a novel optical technique that measures the statistical properties of cell nanoscale organization in terms of the disorder strength. It has been found previously that the increase in the disorder strength of cell nanoarchitecture is one of the earliest events in carcinogenesis. In this study, we investigate the cellular components responsible for the differential disorder strength between two morphologically (and hence microscopically) similar but genetically altered human colon cancer cell lines, HT29 cells and Csk shRNA-transfected HT29 cells that exhibit different degrees of neoplastic aggressiveness. To understand the role of cytoskeleton in nanoarchitectural alterations, we performed selective drug treatment on the specific cytoskeletal components of these cell types and studied the effects of cytoskeletal organization on disorder strength differences. We report that altering the cell nanoarchitecture by disrupting cytoskeletal organization leads to the attenuation of the disorder strength differences between microscopically indistinguishable HT29 and CSK constructs. We therefore demonstrate that cytoskeleton plays a role in the control of cellular nanoscale disorder.
机译:细胞骨架在整个细胞中无处不在,并参与重要的细胞过程,例如细胞转运,信号转导,基因转录,细胞分裂等。部分波谱显微镜技术是一种新颖的光学技术,可以从角度上测量细胞纳米级组织的统计特性。疾病强度。先前已经发现,细胞纳米结构的无序强度的增加是致癌的最早事件之一。在这项研究中,我们调查了两种形态不同(因此在显微镜下)相似但遗传改变的人类结肠癌细胞系HT29细胞和Csk shRNA转染的HT29细胞之间表现出不同程度的肿瘤侵袭性的差异性强度的细胞成分。为了了解细胞骨架在纳米结构改变中的作用,我们对这些细胞类型的特定细胞骨架成分进行了选择性药物治疗,并研究了细胞骨架组织对疾病强度差异的影响。我们报告说,通过破坏细胞骨架组织改变细胞纳米结构会导致微观上无法区分的HT29和CSK构建体之间无序强度差异的减弱。因此,我们证明细胞骨架在细胞纳米级疾病的控制中发挥作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号